Articles with public access mandates - Jeffrey V LazarusLearn more
Not available anywhere: 13
Review
HIV infection
LG Bekker, C Beyrer, N Mgodi, SR Lewin, S Delany-Moretlwe, B Taiwo, ...
Nature Reviews Disease Primers 9 (1), 42, 2023
Mandates: US National Institutes of Health, National Health and Medical Research …
Review
Patient satisfaction with HIV care service in Spain: results from a cross-sectional patient survey
C Burgui, D Guy, U Fresán, M Kall, J Castilla, JV Lazarus
AIDS care 35 (6), 892-898, 2023
Mandates: Government of Spain
Review
Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic Fatty Liver Disease
JV Lazarus, M Villota-Rivas, C Jiménez-González, A Santos-Laso, ...
Clinics in Liver Disease 27 (2), 515-533, 2023
Mandates: Government of Spain
Review
The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe
A Mocroft, A Geressu, C Beguelin, JM Llibre, JV Lazarus, J Tomazic, ...
AIDS 37 (1), 91-103, 2023
Mandates: Swiss National Science Foundation, Danish National Research Foundation …
Review
Liver diseases: A sanitary and social challenge for Europe in the XXI Century. Results of EASL-Lancet Comission
P Ginès, M Buti, JV Lazarus, B Sangro
Medicina Clínica (English Edition) 159 (12), 598-603, 2022
Mandates: European Commission, Government of Spain
Review
Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point‐of‐care
J Valencia, JV Lazarus, FC Ceballos, J Troya, G Cuevas, S Resino, ...
Liver International 42 (2), 309-319, 2022
Mandates: Government of Spain
Review
Detection of active hepatitis C in a single visit and linkage to care among marginalized people using a mobile unit in Madrid, Spain
P Ryan, J Valencia, G Cuevas, J Torres-Macho, J Troya, Á Pueyo, ...
International Journal of Drug Policy 96, 103424, 2021
Mandates: Government of Spain
Review
Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy
JV Lazarus, CA Picchio, D Guy, S Aleman, C James, FA Nava, A Øvrehus, ...
Clinics and Research in Hepatology and Gastroenterology 45 (2), 101564, 2021
Mandates: Banking Foundation "la Caixa", Government of Spain
Review
Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C?
A Palayew, H Razavi, SJ Hutchinson, GS Cooke, JV Lazarus
The Lancet Gastroenterology & Hepatology 5 (10), 948-953, 2020
Mandates: UK Medical Research Council, National Institute for Health Research, UK …
Review
Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject drugs in …
V Saludes, A Antuori, JV Lazarus, C Folch, S González-Gómez, ...
International Journal of Drug Policy 80, 102734, 2020
Mandates: Government of Spain
Review
Epidemiology of hepatitis C virus infection in a country with universal access to direct‐acting antiviral agents: data for designing a cost‐effective elimination policy in Spain
J Crespo, A Cuadrado, C Perelló, J Cabezas, S Llerena, J Llorca, ...
Journal of viral hepatitis 27 (4), 360-370, 2020
Mandates: Government of Spain
Review
France removes hepatitis C treatment prescriber restrictions—but what is the impact of the delay for key populations?
F Marcellin, P Roux, JV Lazarus, B Rolland, P Carrieri
Liver International 39 (12), 2019
Mandates: Agence Nationale de la Recherche
Review
Elimination of hepatitis C virus infection among people who use drugs: ensuring equitable access to prevention, treatment, and care for all
J Grebely, B Hajarizadeh, JV Lazarus, J Bruneau, C Treloar, ...
International Journal of Drug Policy 72, 1-10, 2019
Mandates: National Health and Medical Research Council, Australia, Government of Spain
Available somewhere: 154
Review
Steatotic liver disease and HIV: an agenda for 2030
JM Pericàs, AK Arora, C Riebensahm, A Jiménez-Masip, AR Mena, ...
The Lancet HIV 11 (8), e561-e566, 2024
Mandates: European Commission
Review
Impact of the 2008 economic crisis on the burden of hepatitis B and C diseases in Southern European countries
C Palladino, R Ramis, IJ Ezeonwumelu, A Biondi, G Carreras, F Fischer, ...
BMC Public Health 24 (1), 1642, 2024
Mandates: Bill & Melinda Gates Foundation
Review
The burden of liver disease in Latin America
LA Díaz, M Villota-Rivas, F Barrera, JV Lazarus, M Arrese
Annals of Hepatology 29 (3), 101175, 2024
Mandates: European Commission
Review
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions
AD Marshall, AR Willing, A Kairouz, EB Cunningham, A Wheeler, ...
The Lancet Gastroenterology & Hepatology 9 (4), 366-382, 2024
Mandates: National Health and Medical Research Council, Australia
Review
Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a …
R Sacks-Davis, DK van Santen, A Boyd, J Young, A Stewart, JS Doyle, ...
The Lancet HIV 11 (2), e106-e116, 2024
Mandates: Swiss National Science Foundation, National Health and Medical Research …
Review
Integrated management of HIV, diabetes, and hypertension in sub-Saharan Africa (INTE-AFRICA): a pragmatic cluster-randomised, controlled trial
S Kivuyo, J Birungi, J Okebe, D Wang, K Ramaiya, S Ainan, ...
The Lancet 402 (10409), 1241-1250, 2023
Mandates: UK Medical Research Council, European Commission
Review
Measuring NAFLD models of care
AM Allen, ZM Younossi, EA Tsochatzis, W Alazawi, S Zelber-Sagi, ...
Nature Reviews Gastroenterology & Hepatology 20 (10), 626-627, 2023
Mandates: UK Medical Research Council
Publication and funding information is determined automatically by a computer program